Dermatomyositis and Malignancy Risk: The Predictive Value of Autoantibodies and Patient Risk Factors
Although autoantibody profiling has enhanced risk stratification and informed cancer screening strategies in DM, substantial therapeutic challenges remain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results